☰

Michael R. Garbati, Ph.D. - Publications

Affiliations: 
2010 Boston University, Boston, MA, United States 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lai HY, Brooks SA, Craver BM, Morse SJ, Nguyen TK, Haghighi N, Garbati MR, Fleischman AG. Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm. Blood Advances. 3: 122-131. PMID 30647074 DOI: 10.1182/Bloodadvances.2018026450  0.337
2015 Garbati MR, Welgan CA, Landefeld SH, Newell LF, Agarwal A, Dunlap JB, Chourasia TK, Lee H, Elferich J, Traer E, Rattray R, Cascio MJ, Press RD, Bagby GC, Tyner JW, et al. Mutant calreticulin-expressing cells induce monocyte hyperreactivity through a paracrine mechanism. American Journal of Hematology. PMID 26573090 DOI: 10.1002/Ajh.24245  0.398
2015 Garbati MR, Hays LE, Rathbun RK, Jillette N, Chin K, Al-Dhalimy M, Agarwal A, Newell AE, Olson SB, Bagby GC. Cytokine overproduction and crosslinker hypersensitivity are unlinked in Fanconi anemia macrophages. Journal of Leukocyte Biology. PMID 26432900 DOI: 10.1189/Jlb.3A0515-201R  0.341
2015 Lai HY, Morse SJ, Nguyen TK, Luty SB, Garbati M, Bagby GC, Druker BJ, Fleischman AG. A Blunted Response to the Anti-Inflammatory Cytokine IL-10 Contributes to Excessive TNF Production in Myeloproliferative Neoplasm Blood. 126: 1632-1632. DOI: 10.1182/Blood.V126.23.1632.1632  0.35
2015 Newell LF, Holtan SG, Rosenzweig J, Yates J, Garbati M, Rathbun RK, Keeble W, Tyner JW, Burd I, Bagby GC. Placental Growth Factor Enhances Toll-like Receptor-Induced Inflammatory Cytokine Gene Expression Transcriptionally in Human Mononuclear Phagocytes Blood. 126: 1006-1006. DOI: 10.1182/Blood.V126.23.1006.1006  0.434
2015 Garbati M, Bagby GC. Deficiency of the c-JUN Inhibitor DACH1 in FA Macrophages Accounts for the Cytokine Overproduction Phenotype Blood. 126: 1002-1002. DOI: 10.1182/Blood.V126.23.1002.1002  0.473
2015 Garbati M, Keeble W, Yang W, Bagby GC. Alda-1 Constrains TLR-Induced Cytokine Overproduction By Fanconi Anemia Macrophages By Enhancing ALDH1A1 Activity Blood. 126: 1000-1000. DOI: 10.1182/Blood.V126.23.1000.1000  0.396
2014 Newell LF, Rathbun RK, Garbati MR, Dao KT, Holtan SG, Cook RJ, Meyers G, Bagby GC. The Contribution of Toll-like Receptor (TLR) Pathway Hyper-Reactivity to Clonal Selection in Secondary MDS and AML Blood. 124: 4621-4621. DOI: 10.1182/Blood.V124.21.4621.4621  0.353
2014 Garbati MR, Rathbun RK, Yates JE, Yang W, Bagby GC. ALDH1A1 Dysfunction in FA-Deficient Macrophages Contributes to Aberrant Activation of the Innate Immune Response Blood. 124: 4107-4107. DOI: 10.1182/Blood.V124.21.4107.4107  0.413
2013 Garbati MR, Hays LE, Keeble W, Yates JE, Rathbun RK, Bagby GC. FANCA and FANCC modulate TLR and p38 MAPK-dependent expression of IL-1β in macrophages. Blood. 122: 3197-205. PMID 24046015 DOI: 10.1182/Blood-2013-02-484816  0.351
2013 Fleischman AG, Luty SB, Garbati MR, Edmiston JB, Royer LR, LaTocha DH, Bagby GC, Druker BJ. Exaggerated Response To Toll-Like Receptor Agonist Contributes To Excessive TNF Production In Myeloproliferative Neoplasm Blood. 122: 4097-4097. DOI: 10.1182/Blood.V122.21.4097.4097  0.382
2012 Anur P, Yates J, Garbati MR, Vanderwerf S, Keeble W, Rathbun K, Hays LE, Tyner JW, Svahn J, Cappelli E, Dufour C, Bagby GC. p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes. Blood. 119: 1992-2002. PMID 22234699 DOI: 10.1182/Blood-2011-06-354647  0.487
2012 Garbati MR, Thompson RC, Haery L, Gilmore TD. Erratum to “A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity” [Cancer Lett 302 (2011) 76–83] Cancer Letters. 315: 96. DOI: 10.1016/J.Canlet.2011.09.017  0.662
2011 Garbati MR, Thompson RC, Haery L, Gilmore TD. A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity. Cancer Letters. 302: 76-83. PMID 21232847 DOI: 10.1016/J.Canlet.2010.12.018  0.657
2011 Wolenski FS, Garbati MR, Lubinski TJ, Traylor-Knowles N, Dresselhaus E, Stefanik DJ, Goucher H, Finnerty JR, Gilmore TD. Characterization of the core elements of the NF-κB signaling pathway of the sea anemone Nematostella vectensis. Molecular and Cellular Biology. 31: 1076-87. PMID 21189285 DOI: 10.1128/Mcb.00927-10  0.613
2011 Gilmore TD, Garbati MR. Inhibition of NF-κB signaling as a strategy in disease therapy. Current Topics in Microbiology and Immunology. 349: 245-63. PMID 21113699 DOI: 10.1007/82_2010_105  0.682
2010 Garbati MR, Alço G, Gilmore TD. Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8. Cancer Letters. 291: 237-45. PMID 19948376 DOI: 10.1016/J.Canlet.2009.10.018  0.696
2008 Garbati MR, Gilmore TD. Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation. Gene Expression. 14: 195-205. PMID 19110719 DOI: 10.3727/105221608786883807  0.651
Show low-probability matches.